KR20140024549A - Method for manufacturing functional mushroom rice - Google Patents
Method for manufacturing functional mushroom rice Download PDFInfo
- Publication number
- KR20140024549A KR20140024549A KR1020120090566A KR20120090566A KR20140024549A KR 20140024549 A KR20140024549 A KR 20140024549A KR 1020120090566 A KR1020120090566 A KR 1020120090566A KR 20120090566 A KR20120090566 A KR 20120090566A KR 20140024549 A KR20140024549 A KR 20140024549A
- Authority
- KR
- South Korea
- Prior art keywords
- rice
- mushroom
- ganoderma lucidum
- native
- mycelium
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 111
- 235000009566 rice Nutrition 0.000 title claims abstract description 111
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title abstract description 14
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 117
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 50
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 50
- 235000021329 brown rice Nutrition 0.000 claims abstract description 26
- 238000012258 culturing Methods 0.000 abstract description 6
- 230000003178 anti-diabetic effect Effects 0.000 abstract description 5
- 230000003171 anti-complementary effect Effects 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
- 241000700159 Rattus Species 0.000 description 21
- 206010012601 diabetes mellitus Diseases 0.000 description 21
- 230000002391 anti-complement effect Effects 0.000 description 15
- 108010008730 anticomplement Proteins 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000009630 liquid culture Methods 0.000 description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 244000252132 Pleurotus eryngii Species 0.000 description 6
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 6
- 235000018823 dietary intake Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 241001264174 Cordyceps militaris Species 0.000 description 5
- 240000000599 Lentinula edodes Species 0.000 description 5
- 235000001715 Lentinula edodes Nutrition 0.000 description 5
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 5
- 240000001462 Pleurotus ostreatus Species 0.000 description 5
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 5
- 241000001727 Tropicoporus linteus Species 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000000496 pancreas Anatomy 0.000 description 5
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000003914 insulin secretion Effects 0.000 description 4
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 4
- 241000221377 Auricularia Species 0.000 description 3
- 240000000588 Hericium erinaceus Species 0.000 description 3
- 235000007328 Hericium erinaceus Nutrition 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 235000006894 Primula auricula Nutrition 0.000 description 3
- 210000000702 aorta abdominal Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 231100000234 hepatic damage Toxicity 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000008818 liver damage Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 241000750142 Auricula Species 0.000 description 2
- 244000028550 Auricularia auricula Species 0.000 description 2
- 235000000023 Auricularia auricula Nutrition 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 241000289667 Erinaceus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000123222 Hericium Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 240000003173 Drymaria cordata Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001088162 Primula auricula Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/196—Products in which the original granular shape is maintained, e.g. parboiled rice
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 기능성 토종 버섯 쌀 및 그 제조방법에 관한 기술로, 구체적으로는 토종 쌀에 영지버섯의 균사체를 접종하여 배양시킴으로써 제조되는 기능성 토종 버섯쌀에 관한 기술이다.
The present invention relates to a functional indigenous mushroom rice and a method for manufacturing the same, and specifically, a technique related to a functional indigenous mushroom rice prepared by inoculating and incubating a mycelium of Ganoderma lucidum on a native rice.
우리나라는 농경을 시작하던 기원전 6∼7세기경부터 삼국시대를 거치는 동안에 농업국으로서 농산물이 주요 식량원이 되었다. 특히, 쌀을 비롯한 곡류는 우리에게 주식으로서 지금까지 자리를 하고 있다. 현재 우리나라 1인당 연간 쌀 소비량은 1979년 135.6 kg을 정점으로 2003년 83.2 kg, 2007년 76.9 kg으로 급격히 감소하고 있다. 이는 식생활 패턴이 밥에서 패스트푸드나 인스턴트식품으로 전환되었기 때문이다. 이에 따라 국민건강을 위협하는 성인병 발생이 증가 되고 있다.During the Three Kingdoms period from the 6th to 7th century BC, when agricultural farming began, agricultural products became the main food source. In particular, grains, including rice, have served as our staple food so far. Currently, per capita annual rice consumption in Korea peaked at 135.6 kg in 1979 and has been rapidly decreasing to 83.2 kg in 2003 and 76.9 kg in 2007. This is because eating patterns have shifted from rice to fast food or instant food. As a result, the incidence of adult diseases threatening public health is increasing.
한편, 쌀의 영양학적 우수성이 집중되면서 쌀의 기호성뿐 아니라 기능적 우수성에 대한 연구가 활발히 진행되고 있다. 그레이포(Grapo) 등은 감자나 식빵보다 쌀밥 섭취 시 혈당 및 인슐린 분비가 낮고, 쌀밥 형태가 가루나 죽, 떡 등 가공형태보다 혈당량의 급격한 증가나 인슐린 분비를 억제한다고 보고하였고, 김 등은 백미에는 돌연변이억제 활성이 있으며 가공형태인 밥, 백설기, 미숫가루 등도 억제활성이 소실되지 않아 항돌연변이 활성이 존재함을 보고하였다. 토종 쌀 또한 영양학적 우수성이 부각되면서 병충해 등의 친환경 재배법의 해결 방안으로도 큰 장점을 지니고 있다. 이에 최근 우리의 유전자원을 보존하고, 지역의 토종자원 활성화와 친환경농업 실현을 위해 토종 쌀의 연구가 활발히 진행되고 있다.On the other hand, as the nutritional excellence of rice is concentrated, research on functional excellence as well as palatability of rice is being actively conducted. Grapo et al reported that blood sugar and insulin secretion were lower when ingesting rice than potatoes and white bread, and that the rice form suppressed the rapid increase in blood sugar levels and insulin secretion compared to processed forms such as flour, porridge, and rice cake, and Kim et al. In addition, mutagenic activity was observed, and processed forms of rice, white snow, and rice flour did not lose their inhibitory activity, and antimutagenic activity was reported. Indigenous rice also has great benefits as a solution to environmentally friendly cultivation methods such as pests due to its nutritional excellence. Recently, research on native rice has been actively conducted to preserve our genetic resources, revitalize local resources and realize eco-friendly agriculture.
담자균류에 속하는 버섯은 생리활성 물질이나 기능성 성분에 대한 연구가 활발히 진행되어 항암성, 면역활성증강, 혈당강하, 지질저하, 혈중 콜레스테롤 저하 작용 등이 과학적으로 입증되었으며 일부 기능성 물질이 추출, 정제되어 의약품으로 상품화되기도 하였다. 이와 같은 효능을 나타내는 성분은 베타 글루칸(β-glucan), 헤테로글리칸(heteroglycan), 글라이코프로틴(glycoprotein) 등의 비소화성의 수용성 다당류로서 건물량으로 버섯의 약 10% 이상을 차지하고 있다. Mushrooms belonging to basidiomycetes have been actively researched for bioactive substances and functional ingredients, and have been scientifically proven to have anti-cancer activity, immune activity enhancement, hypoglycemia, lowering lipids, lowering blood cholesterol, and some functional substances have been extracted and purified. It has also been commercialized as a drug. Ingredients exhibiting such efficacy are non-digestible, water-soluble polysaccharides such as beta glucan, beta glucan, heteroglycan, and glycoprotein, and occupy about 10% or more of mushrooms in dry weight.
버섯 활용방법으로 자실체를 이용하거나 균사체를 액체 배양하여 유용성분을 분리, 정제하는 방법들이 주로 이용되는데, 자실체를 이용하는 경우 일부 버섯은 자실체로의 인공 재배가 불가능하거나 가격이 비싸기 때문에 산업적으로 대중화하기에 한계가 있으며, 균사체를 액체 배양하는 경우 유용성분을 분리, 정제하는데 많은 비용이 소요되는 단점이 있다. 한편 버섯 균을 곡물에 접종하여 배양하는 고체배양기술이 버섯 활용의 한 방법으로 이용되고 있는데, 이는 유용성분을 얻기 위한 별도의 추출, 정제공정이 필요 없으며, 배양물 전체를 일반 곡물처럼 손쉽게 섭취할 수 있기 때문에 소비자의 건강증진에 기여함은 물론 국내산 곡물의 부가가치를 증대시킬 수 있는 장점이 있다.
As a method of using mushrooms, fruiting bodies or liquid culture of mycelium are used to isolate and purify useful components.In the case of using fruiting bodies, some mushrooms cannot be artificially grown in fruiting bodies or are expensive, and thus they are popular for industrialization. There are limitations and disadvantages in that the liquid culture of the mycelium is expensive to separate and purify the useful components. On the other hand, solid culture technology that inoculates mushrooms and incubates them into grains is used as a method of utilizing mushrooms, which does not require a separate extraction and purification process to obtain useful ingredients. Because of this, it contributes to the health promotion of consumers, and has the advantage of increasing the added value of domestic grains.
본 발명은 토종 백미 또는 현미에 영지버섯 균사체를 배양하여 제조한 기능성 토종 버섯 쌀을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a functional indigenous mushroom rice prepared by culturing Ganoderma lucidum mycelium in native white rice or brown rice.
또한, 본 발명은 당뇨 환자를 위한 면역증강과 혈당강하 효과가 우수한 기능성 토종 버섯 쌀을 제공하는 것을 목적으로 한다.
In addition, an object of the present invention is to provide a functional native mushroom rice excellent in the immune boosting and hypoglycemic effect for diabetic patients.
상기 목적을 달성하기 위하여 본 발명은 토종 백미에 영지버섯 균사체를 7.5~12.5%(w/w) 접종하여 27~29℃에서 8~10일간 배양함으로써 제조되는 토종 백미 버섯 쌀의 제조방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing native white rice mushroom rice, which is prepared by inoculating 7.5-12.5% (w / w) Ganoderma lucidum mycelium on native white rice and incubating at 27-29 ° C. for 8 to 10 days. .
또한, 본 발명은 토종 현미에 영지버섯 균사체를 7.5~12.5%(w/w) 접종하여 27~29℃에서 8~10일간 배양함으로써 제조되는 토종 현미 버섯 쌀의 제조방법을 제공한다.In another aspect, the present invention provides a method for producing a native brown rice mushroom rice prepared by inoculating 7.5 ~ 12.5% (w / w) in Gaji mushroom mycelium in native brown rice and incubated for 8 to 10 days at 27 ~ 29 ℃.
본 발명에서는 영지버섯 균사체를 사용하는데, 하기 본 발명의 실험에 의하면 영지(Ganodema lucidum), 느타리(Pleurotus ostreatus), 큰느타리(Pleurotus eryngii), 노루궁뎅이(Hericium erinaceus), 목질진흙(Phellinus linteus), 동충하초(Cordyceps militaris), 및 표고(Lintus edodes) 및 목이(Auricularia auricula -jude) 버섯의 균사체를 배양하고 항보체 활성을 조사한 결과, 영지버섯이 가장 높은 항보체 활성을 나타내었기 때문이다. In the present invention, ganoderma lucidum mycelium is used, according to the experiment of the present invention Ganoderma Ganodema lucidum ), Pleurotus ostreatus ), Pleurotus eryngii ), Hericium beetle erinaceus ), Phellinus linteus , Cordyceps militaris ), and shiitake ( Lintus edodes and sore throat ( Auricularia) Auricula -jude ) cultured mycelia and anti-complement activity showed that Ganoderma lucidum showed the highest anti-complement activity.
또한, 본 발명은 영지버섯 균사체를 7.5~12.5%(w/w) 접종하는데, 균사체배양액의 함량이 7.5% 미만이면 기대하는 효과를 얻기 어려울 수 있으며, 12.5%를 초과하면 첨가량만큼의 현저한 효과 상승이 나타나지 않을 수 있어 경제적이지 못하다. In addition, the present invention inoculate the Ganoderma lucidum mycelium 7.5 ~ 12.5% (w / w), if the content of the mycelium culture medium is less than 7.5% can be difficult to obtain the expected effect, when exceeding 12.5% significant effect increase by the amount added It may not appear economically.
한편, 본 발명에 있어서, 영지버섯 균사체를 배양하는 방법으로는, 본 발명이 속하는 기술분야에서 통상적으로 사용되는 배양 방법을 이용할 수 있다. 바람직하게는, 엠씨엠(MCM, mushroom complete medium; glucose 2%, MgSO47H2O 0.05%, KH2PO4 0.046%, K2HPO4 0.1%, yeast extract 0.2%, peptone 0.2%, pH 4.5) 배지에서 온도 30~33℃로 액체 배양하는 것이 좋다.In the present invention, as a method for culturing Ganoderma lucidum mycelium, a culture method commonly used in the art to which the present invention pertains may be used. Preferably, MCM (MCM, mushroom complete medium;
한편, 영지버섯(Ganodema lucidum)은 여름에 활엽수 뿌리에서 발생하며, 진시황의 불로초라고도 알려져 있고, 본초강목은 인삼과 함께 이 버섯을 상약의 반열에 올려놓았다고 알려져 있다. 강장, 진해, 소종(消腫) 등의 효능이 있어 호흡기 질환, 신경쇠약, 심장병, 고혈압 등에 효과가 있고 콜레스테롤을 낮춰주며 항암 효과가 있는 것으로 알려져 있다.On the other hand, Ganodema mushroom lucidum ) occurs in the broad-leaved roots in summer and is also known as the Bulchocho of Qin Shi Huang. Tonic, Jinhae, swelling (효능) and the effect is effective in respiratory diseases, nervous breakdown, heart disease, high blood pressure, lower cholesterol and anti-cancer effects are known.
또한, 본 발명의 기능성 토종 버섯 쌀은 쌀을 이용하는 다양한 형태의 식품으로 제조될 수 있다. 일예로 쌀 음료, 쌀 과자, 떡, 죽 등으로 제조될 수 있다.In addition, the functional native mushroom rice of the present invention can be prepared in various forms of food using rice. For example, it may be prepared from rice drinks, rice cakes, rice cakes, porridge, and the like.
이와 같이 제조된 본 발명의 기능성 토종 버섯 쌀은 항보체 활성 및 항당뇨 효과가 우수하여 당뇨 환자들에게 제공할 수 있다는 장점이 있다. 또한, 버섯 균사체 배양물 전체를 일반 쌀처럼 손쉽게 섭취할 수 있기 때문에 소비자의 건강증진에 기여할 수 있다.
Functional native mushroom rice of the present invention prepared as described above has an advantage that can be provided to diabetic patients with excellent anti-complement activity and anti-diabetic effect. In addition, the mushroom mycelium culture can be easily consumed as a whole rice, so it can contribute to the health of consumers.
본 발명은 토종 백미 또는 현미에 영지버섯 균사체를 배양함으로써, 생리활성을 가진 기능성 토종 버섯 쌀을 제공할 수 있다.The present invention can provide a functional native mushroom rice with physiological activity by culturing the Ganoderma lucidum mycelium in native white rice or brown rice.
또한, 본 발명의 기능성 토종 버섯 쌀은 면역증강과 혈당강하 효과가 있어 당뇨 환자를 위한 식품의 개발과 소비를 촉진할 수 있다.
In addition, the functional native mushroom rice of the present invention has an immune enhancing and hypoglycemic effect, thereby promoting the development and consumption of food for diabetic patients.
도 1은 8종 버섯의 균사체 생산량을 나타낸 그래프이다[GL: 영지버섯(Ganodema lucidum), PO: 느타리버섯(Pleurotus ostreatus), PE: 큰느타리버섯(Pleurotus eryngii), HE: 노루궁뎅이버섯(Hericium erinaceus), PL: 목질진흙버섯(Phellinus linteus), CM: 동충하초버섯(Cordyceps militaris), LE: 표고버섯(Lintus edodes), AA: 목이버섯(Auricularia auricula - jude)].
도 2는 8종 버섯의 버섯 균사체 액체배양으로부터 세포 내 다당체를 회수하는 과정을 개략적으로 나타낸 도이다.
도 3은 8종의 버섯 균사체의 항보체 활성을 나타낸 그래프이다 [GL: 영지버섯(Ganodema lucidum), PO: 느타리버섯(Pleurotus ostreatus), PE: 큰느타리버섯(Pleurotus eryngii), HE: 노루궁뎅이버섯(Hericium erinaceus), PL: 목질진흙버섯(Phellinus linteus), CM: 동충하초버섯(Cordyceps militaris), LE: 표고버섯(Lintus edodes), AA: 목이버섯(Auricularia auricula - jude), LPS: Lipopolysaccharide].
도 4는 pH에 따른 영지버섯의 균사체 생산량을 나타낸 그래프이다.
도 5는 온도에 따른 영지버섯의 균사체 생산량을 나타낸 그래프이다.
도 6은 토종 쌀을 이용하여 버섯 균사체를 배양하는 과정을 개략적으로 나타낸 도이다.
도 7은 배양 중인 버섯 쌀(A)와 배양된 백미 영지버섯 쌀(B), 현미 영지버섯 쌀(C)의 사진이다.
도 8은 영지버섯 쌀의 항보체 활성을 나타낸 그래프이다(GL: 영지버섯, NR: 토종 쌀, NRCGL: 토종 영지버섯 쌀, LPS: Lipopolysaccharide).
도 9는 토종 영지버섯 쌀의 섭취에 따른 실험 쥐의 체중 변화를 나타낸 그래프이다.
도 10은 토종 영지버섯 쌀의 섭취에 따른 실험 쥐의 식이 섭취량 변화를 나타낸 그래프이다.
도 11은 토종 영지버섯 쌀의 섭취에 따른 실험 쥐의 혈중 혈당 변화를 나타낸 그래프이다.1 is a graph showing the mycelial production of eight mushrooms [GL: Ganoderma lucidum ( Ganodema) lucidum ), PO: Pleurotus ostreatus ), PE: Pleurotus eryngii ), HE: Hericium erinaceus ), PL: Phellinus linteus ), CM: Cordyceps militaris ), LE: Shiitake ( Lintus edodes ), AA: Auricularia auricula - jude )].
Figure 2 is a schematic diagram illustrating a process for recovering the intracellular polysaccharides from the liquid culture mycelium culture of eight mushrooms.
3 is a graph showing the anti-complement activity of eight mushroom mycelium [GL: Ganoderma lucidum ( Ganodema) lucidum ), PO: Pleurotus ostreatus ), PE: Pleurotus eryngii ), HE: Hericium erinaceus ), PL: Phellinus linteus ), CM: Cordyceps militaris , LE: Shiitake ( Lintus) edodes ), AA: Auricularia auricula - jude ), LPS: Lipopolysaccharide].
Figure 4 is a graph showing the mycelium production of Ganoderma lucidum according to pH.
5 is a graph showing the mycelium production of Ganoderma lucidum according to temperature.
6 is a view schematically showing a process of culturing mushroom mycelium using native rice.
Figure 7 is a photograph of the mushroom rice (A) and cultured white rice Ganoderma lucidum rice (B), brown rice Ganoderma lucidum rice (C) in culture.
8 is a graph showing the anti-complement activity of Ganoderma lucidum rice (GL: Ganoderma lucidum mushroom, NR: native rice, NRCGL: native Ganoderma lucidum rice, LPS: Lipopolysaccharide).
9 is a graph showing the weight change of the experimental rat according to the intake of native Ganoderma lucidum rice.
10 is a graph showing the change in dietary intake of experimental rats according to the intake of native Ganoderma lucidum rice.
Figure 11 is a graph showing the blood glucose changes in experimental rats according to the intake of native Ganoderma lucidum rice.
이하, 본 발명의 내용에 대해 하기 실시예에서 더욱 상세히 설명하지만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 이와 등가의 기술적 사상의 변형까지 포함한다.
Hereinafter, the content of the present invention will be described in more detail in the following examples, but the scope of the present invention is not limited only to the following examples, and includes modifications of equivalent technical ideas.
[[ 실시예Example 1: 버섯 균사체 배양] 1: Mushroom Mycelial Culture]
본 실시예 8종의 버섯의 균사체 생산량을 비교하고자 하였다.In this example, the mycelial production of eight mushrooms was compared.
영지(Ganodema lucidum), 느타리(Pleurotus ostreatus), 큰느타리(Pleurotus eryngii), 노루궁뎅이(Hericium erinaceus), 목질진흙(Phellinus linteus), 동충하초(Cordyceps militaris), 표고(Lintus edodes) 및 목이(Auricularia auricula -jude) 버섯을 준비하고, 이들을 엠씨엠(MCM, mushroom complete medium; glucose 2%, MgSO47H2O 0.05%, KH2PO4 0.046%, K2HPO4 0.1%, yeast extract 0.2%, peptone 0.2%, pH 4.5] 배지로 액체 배양하였다. Ganodema lucidum ), Pleurotus ostreatus ), Pleurotus eryngii , Herringium ( Hericium) erinaceus ), Phellinus linteus ), Cordyceps militaris ), shiitake ( Lintus edodes and sore throat ( Auricularia) auricula -jude ) prepared mushrooms, these were MCM (mushroom complete medium;
배양결과, 같은 조건에서 영지버섯과 느타리버섯의 균사체 생산량이 가장 많은 것으로 나타났다(도 1 참조).
As a result of the culture, mycelium production of Ganoderma lucidum and Pleurotus eryngii was the highest under the same conditions (see FIG. 1).
[[ 실험예Experimental Example 1: 버섯 균사체 1: Mushroom Mycelium 항보체Anti-complement 활성 비교] Active comparison]
본 실험예에서는 상기 실시예 1에서 제조한 영지(Ganodema lucidum), 느타리(Pleurotus ostreatus), 큰느타리(Pleurotus eryngii), 노루궁뎅이(Hericium erinaceus), 목질진흙(Phellinus linteus), 동충하초(Cordyceps militaris), 표고(Lintus edodes) 및 목이(Auricularia auricula - jude) 버섯의 균사체 액체배양으로부터 세포 내 다당체를 회수하여 항보체 활성을 측정하고자 하였다(도 2 참조).Prepared in Example 1. In this experiment, for example, Ling Zhi (Ganodema lucidum ), Pleurotus ostreatus ), Pleurotus eryngii ), Hericium erinaceus , Phellinus linteus ), Cordyceps militaris ), shiitake ( Lintus edodes and sore throat ( Auricularia) Auricula - jude ) was intended to measure the anti-complement activity by recovering the intracellular polysaccharide from the mycelium liquid culture of the mushroom (see Fig. 2).
항보체 활성은 메이어(Mayer)법으로 측정하였다. 엔에이치에스(NHS, Normal Human Serum), 지브이비(GVB++, Gelatin Veronal Buffered saline, pH 7.2)와 시료를 각각 50 ㎕씩 혼합하여 37℃에서 30분간 반응시킨 후 반응액에 지브이비(GVB++)를 350 ㎕씩 첨가하고, 이를 10배에서 160배까지 연속 희석하여 750 ㎕의 지브이비(GVB++)와 양의 감작혈구(108 cells/㎖)를 250 ㎕씩 가하여 1시간 동안 반응시킨 다음 반응정지용액 피비에스(PBS, Phosphate Buffered Saline, pH 7.4)를 2.5 ㎖씩 가하여 원심 분리한 후 상등액의 흡광도를 412 nm에서 측정하였다.Anti-complement activity was measured by the Mayer method. 50 μL of NHS (NHS, Normal Human Serum), GVB ++ (GVB ++, Gelatin Veronal Buffered saline, pH 7.2) and the sample are mixed and reacted at 37 ° C for 30 minutes, and then GVB ++ is added to the reaction solution. 350 μl each was added, and serial dilutions were carried out from 10 to 160 times. 750 μl of GIBB (GVB ++) and positive sensitized blood cells (108 cells / mL) were added and then 250 μl each was reacted for 1 hour. 2.5 ml of PBS (PBS, Phosphate Buffered Saline, pH 7.4) was added thereto, followed by centrifugation, and the absorbance of the supernatant was measured at 412 nm.
항보체 활성은 아이티씨에이치50(ITCH50), 총 보체 용혈 저지율 (Inhibition of 50% Total Complement Hemolysis)로 나타낸다. 시료의 정확한 활성을 검증하기 위하여 역가를 알고 있는 엘피에스(LPS)를 표준물질로 한다. 계산방법은 하기 수학식 1과 같다.Anti-complement activity is indicated by ITCH50, Inhibition of 50% Total Complement Hemolysis. In order to verify the correct activity of the sample, LPS (LPS) with known titer is used as a reference material. The calculation method is shown in
측정 결과(도 3 참조), 표준물질인 엘피에스(LPS) 보다는 낮았지만, 영지버섯과 상황버섯이 아이티씨에이치50(ITCH50)값이 70을 넘어 가장 높은 활성을 보였다. As a result of the measurement (see FIG. 3), the LPS (LPS), a standard, but lower than the Ganoderma lucidum and situation mushrooms showed the highest activity over the 70 (ITCH 50 ) value over 70.
균사체 생산량과 항보체 활성을 고려한 결과, 영지버섯이 가장 높은 균사체 생산량과 항보체 활성을 나타내어 토종버섯 쌀 생산을 위한 버섯은 영지버섯으로 결정하였다.
As a result of considering mycelial production and anti-complement activity, Ganoderma lucidum showed the highest mycelial production and anti-complement activity.
[[ 실시예Example 2: 영지버섯 균사체 액체배양 조건 비교] 2: Comparison of Liquid Culture Conditions for Ganoderma lucidum Mycelium]
본 실시예에서는 높은 균사체 생산을 위하여 영지버섯의 액체배양 조건을 확립하고자 하였다.In this example, it was intended to establish the liquid culture conditions of Ganoderma lucidum for high mycelial production.
실시결과, pH는 4.5와 5.0에서(도 4 참조), 온도는 30℃에서(도 5 참조) 가장 높은 균사체 생산량을 나타내었다. 이로써, 영지버섯 균사체 액체배양의 최적의 배양 조건은 pH 4.5와 온도 30℃임을 확인하였다.
The results showed the highest mycelial yields at pH 4.5 and 5.0 (see FIG. 4) and temperature at 30 ° C. (see FIG. 5). As a result, it was confirmed that the optimum culture conditions of Ganoderma lucidum mycelium liquid culture was pH 4.5 and the
[[ 실시예Example 3: 배양 조건에 따른 토종 쌀을 이용한 버섯 균사체 배양] 3: Mushroom Mycelial Culture Using Native Rice According to Culture Conditions]
본 실시예에서는 배양 조건에 따른 버섯 쌀의 배양 형태를 비교하고자 하였다(도 6 참조).
In this example, to compare the culture form of mushroom rice according to the culture conditions (see Figure 6).
실시예Example 3-1: 토종 쌀의 투입량에 따른 버섯 쌀의 배양 형태 및 기간 비교 3-1: Comparison of Culture Type and Duration of Mushroom Rice According to Native Rice Input
쌀의 멸균을 위해 멸균 가능한 봉투의 크기가 32*44.5 cm인 곳에 쌀을 1~2.5 kg까지 넣어 멸균한 다음 하룻밤 동안 물에 침지한 후 물을 빼고 비닐봉지에 수침한 곡물을 담고 오토클레이브(autoclave)로 고압 살균 처리하였다. 고압 살균 처리된 토종 쌀에 액체배양한 영지버섯 균사체를 접종한 후 25℃로 고정된 배양기에서 2~3주간 배양하였다. To sterilize the rice, sterilize it with 1 ~ 2.5 kg of rice in a sterilizable bag size of 32 * 44.5 cm, and soak it in water overnight, drain the water and put the grain soaked in the plastic bag. Autoclaved). After inoculating liquid cultured Ganoderma lucidum mycelium on autoclaved indigenous rice and incubated for 2 to 3 weeks in an incubator fixed at 25 ℃.
실시결과(표 1 참조), 토종 쌀 1 kg을 이용할 때가 물리적 형태나 배양기간이 최적으로 나타났다.
As a result (see Table 1), 1 kg of native rice showed the best physical form and incubation period.
실시예Example 3-2: 접종량에 따른 버섯 쌀의 배양 형태 및 기간 비교 3-2: Comparison of Culture Type and Duration of Mushroom Rice According to Inoculation Volume
쌀의 멸균을 위해 멸균 가능한 봉투의 크기가 32*44.5 cm인 곳에 동량의 쌀을 넣고 멸균한 다음 하룻밤 동안 물에 침지한 후 물을 빼고 비닐봉지에 수침한 곡물을 담고 오토클레이브(autoclave)로 고압 살균 처리하였다. 고압 살균 처리된 토종 쌀에 액체배양한 영지버섯 균사체를 5~17.5%까지 접종한 후 25℃로 고정된 배양기에서 2~3주간 배양하였다. To sterilize the rice, put the same amount of rice in a sterilizable bag size of 32 * 44.5 cm and sterilize it. Sterilized. After inoculating up to 5 ~ 17.5% in liquid cultured Ganoderma lucidum mycelium in high pressure sterilized indigenous rice was incubated for 2 to 3 weeks in a fixed incubator at 25 ℃.
실시결과(표 2 참조), 토종 쌀에 영지버섯 균사체 배양액을 10% 접종하였을 때 물리적 형태나 배양기간이 최적으로 나타났다.
As a result (see Table 2), 10% inoculation of Ganoderma lucidum mycelium culture medium in native rice showed the optimum physical form and incubation period.
실시예Example 3-3: 온도에 따른 버섯 쌀의 배양 형태 및 기간 비교 3-3: Comparison of Culture Type and Duration of Mushroom Rice According to Temperature
쌀의 멸균을 위해 멸균 가능한 봉투의 크기가 32*44.5 cm인 곳에 동량의 쌀을 넣고 멸균한 다음 하룻밤 동안 물에 침지한 후 물을 빼고 비닐봉지에 수침한 곡물을 담고 오토클레이브(autoclave)로 고압 살균 처리하였다. 고압 살균 처리된 토종 쌀에 액체배양한 영지버섯 균사체를 접종한 후 온도를 22~90℃로 배양기에서 2~3주간 배양하였다.To sterilize the rice, put the same amount of rice in a sterilizable bag size of 32 * 44.5 cm and sterilize it. Sterilized. After inoculating liquid cultured Ganoderma lucidum mycelium on autoclaved indigenous rice, the temperature was incubated for 2 to 3 weeks in an incubator at 22-90 ° C.
실시결과(표 3 참조), 배양온도 28℃일 때 물리적 형태나 배양기간이 최적으로 나타났다.As a result (see Table 3), the physical form and the incubation period were optimal when the culture temperature was 28 ℃.
실시예Example 3-4. 배양기간에 따른 버섯 쌀 배양 형태 비교 3-4. Comparison of Mushroom Rice Culture Types According to Culture Period
쌀의 멸균을 위해 멸균 가능한 봉투의 크기가 32*44.5 cm인 곳에 동량의 쌀을 넣고 멸균한 다음 하룻밤 동안 물에 침지한 후 물을 빼고 비닐봉지에 수침한 곡물을 담고 오토클레이브(autoclave)로 고압 살균 처리하였다. 고압 살균 처리된 토종 쌀에 액체배양한 영지버섯 균사체를 접종한 후 온도를 25℃로 고정된 배양기에서 8~13일간 배양하였다. To sterilize the rice, put the same amount of rice in a sterilizable bag size of 32 * 44.5 cm and sterilize it. Sterilized. After inoculating liquid cultured Ganoderma lucidum mycelium on autoclaved indigenous rice, the temperature was incubated for 8 to 13 days in an incubator fixed at 25 ° C.
실시결과(표 4 참조), 색감은 배양기간이 9일과 10일 때 가장 좋았고, 버섯 향은 12일째에서 가장 진하게 나타났으며, 물리적 형태는 8일에서 13일 사이 모두 양호하였다. 전체적으로 비교한 결과, 배양기간으로 9일이 가장 적합한 것으로 판단하였다. In the results (see Table 4), color was the best when the culture period was 9 days and 10 days, mushroom flavor was the strongest at 12 days, the physical shape was good between 8 and 13 days. As a result of comparison, it was determined that 9 days was the most suitable for the culture period.
따라서, 본 발명에서는 토종 쌀에 영지버섯 종균 10%를 접종하여 28℃에서 9일간 배양하는 것이 토종 버섯 쌀의 최적 배양조건임을 확인하였다.Therefore, in the present invention, inoculating 10% of Ganoderma lucidum spawn seed on native rice and culturing for 9 days at 28 ° C confirmed that the optimal culture condition of native mushroom rice.
[[ 실험예Experimental Example 2: 토종 영지버섯 쌀의 2: of native Ganoderma lucidum rice 항보체Anti-complement 활성 측정] Activity measurement]
본 실험예에서는 상기 실시예 3을 통해 확립된 최적의 배양조건으로 제조된 토종 영지버섯 쌀의 항보체 활성을 측정하고자 하였다.In this experimental example, the anti-complement activity of native Ganoderma lucidum rice prepared under the optimum culture conditions established in Example 3 was measured.
측정 방법은 상기 실험예 1에서 기술과 동일한 방법으로 수행하였다.The measuring method was performed by the same method as described in Experimental Example 1.
측정결과(도 8 참조), 토종 영지버섯 쌀이 영지버섯 자체보다는 항보체 활성이 낮지만 토종 쌀 보다는 높은 것으로 보아, 영지버섯 쌀의 항보체 활성을 확인할 수 있었다.
As a result of the measurement (see FIG. 8), the native Ganoderma lucidum rice had a lower anticomplement activity than the Ganoderma lucidum itself, but was higher than that of native ganoderma lucidum, and thus the anticomplement activity of Ganoderma lucidum rice was confirmed.
[[ 실험예Experimental Example 3: 토종 영지버섯 쌀의 3: native Ganoderma lucidum rice 항당뇨Anti-diabetic 활성 측정] Activity measurement]
실험예Experimental Example 3-1: 실험 준비 3-1: Preparing the Experiment
먼저, 체중이 100~120 g인 스프래그-다을리(Sprague-Dawley)계 수컷 흰쥐를 대한 실험동물 센터에서 구입하여 22±0.5℃, 습도 55±5%, 12시간의 명암 사이클을 유지하는 사육실에서 스테인레스 스틸 케이스(stainless steel cage)에 1마리씩 분리하여 일주일간 실험실 환경에 적응시킨 다음 실험에 사용하였다. First, Sprague-Dawley male rats weighing 100-120 g were purchased from the experimental animal center and maintained at 22 ± 0.5 ° C, 55 ± 5% humidity, and a 12-hour light cycle. One by one in a stainless steel cage (Stainless steel cage) was adapted to the laboratory environment for a week and then used in the experiment.
또한, 당뇨 유발은 췌장의 베타-셀(β-cell)에만 특이적으로 작용하여 다른 기관에는 영향을 주지 않으며, 인슐린(insulin)의 결핍으로 고혈당을 유발시킨다고 알려져 있는 스트렙토조토신(streptozotocin, STZ)을 0.1 M 시트르산염(citrate)에 용해시켜 근육 주사(50 ㎎/㎏ body weight)하며, 당뇨 유발 확인은 스트렙토조토신(streptozotocin, STZ)을 주사한지 24시간 후에 꼬리 정맥에서 채혈한 혈액의 혈당량이 300 ㎎/㎗ 이상인 것을 당뇨 쥐로 간주하여 실험에 사용하였다. 고혈당이 유발된 흰쥐를 각 군당 8마리로 하여 혈당값과 평균체중이 유사하도록 배치시키고, 실험기간 동안 물과 사료는 자유롭게 섭취하게 하였다. In addition, diabetes induction affects only the beta-cell of the pancreas and does not affect other organs, and streptozotocin (STZ), which is known to cause hyperglycemia due to lack of insulin Was dissolved in 0.1 M citrate and injected intramuscularly (50 mg / kg body weight). The blood glucose level in the tail vein was measured 24 hours after streptozotocin (STZ) injection. 300 mg / dl or more was considered diabetic rat and used for experiment. Hyperglycemic-induced rats of 8 rats were placed in each group to have similar blood glucose values and mean weight, and water and feed were freely consumed during the experiment.
당뇨 유발 실험군들은 사료로 토종 백미와 현미를 먹인 군과, 토종 백미와 현미 버섯 쌀을 먹인 군 그리고 염분(saline)을 먹인 대조군으로 구별한 후, 사료를 2주 동안 체중 ㎏당 100 ㎎을 경구투여 하였다. 당뇨 유발 후 2일에 한번씩 실험 쥐의 꼬리에서 채혈하여 혈당치를 측정하였다. 실험동물의 체중은 오전의 일정한 시간에 매일 측정하며, 사료 섭취량은 각 실험 군별로 체중 측정 직전에 잔량을 수거하여 측정하였다. Diabetes-induced experimental groups were divided into the group fed with native white rice and brown rice, the group fed with native white rice and brown rice mushroom rice, and the control group fed with saline, and then orally administered the
또한, 실험결과들은 에스피에스에스(SPSS, statistical package of social science) 프로그램을 이용하여 분석, 비교하였고, 분산분석(ANOVA, analysis of variance)을 통해 실험군별로 평균(mean)±표준오차(SE)로 나타내었다. 각 실험군 간의 평균치의 통계적 유의성은 p< 0.05 수준에서 던컨의 다중검정(Duncan's multiple range test)에 의해 검정하였다.
In addition, the experimental results were analyzed and compared using the statistical package of social science (SPSS) program, and expressed as mean ± standard error (SE) for each experimental group through analysis of variance (ANOVA). It was. The statistical significance of the mean value between each experimental group was tested by Duncan's multiple range test at p <0.05.
실험예Experimental Example 3-2: 토종 버섯 쌀 섭취에 따른 실험 쥐의 체중 및 식이 섭취량 변화 비교 3-2: Comparison of Body Weight and Dietary Intake of Rats with Indigenous Mushroom Rice
토종 백미 영지버섯 쌀과 토종 현미 영지버섯 쌀을 당뇨 유발 실험 쥐에게 14일간 급여 후 각 군의 체중 및 식이 섭취량을 비교하였다.Native white rice Ganoderma lucidum rice and native brown rice Ganoderma lucidum rice were fed to diabetic rats for 14 days, and then the weight and dietary intake of each group were compared.
각 군의 체중의 비교결과(도 9 참조), 대조군(Control)보다 당뇨 유발군들이 사육 시간이 지날수록 체중이 증가하였으나, 정상군(Normal)보다는 적은 체중이었다. 이는 스트렙토조토신(Streptozotocin)이 췌장의 베타 셀(β-cell)을 선택적으로 파괴하여 인슐린(insulin) 생성의 이상을 초래하여 당대사의 불균형을 일으켜 체중이 쉽게 회복되지 않기 때문으로 판단된다. 그러나 당뇨 유발 실험군 중에서 토종 백미와 현미 영지버섯 쌀 투여 군들이 대조군보다 체중 증가가 많이 되는 것으로 보아 영지버섯 쌀 섭취에 의해 스트렙토조토신(Streptozotocin)으로 당뇨가 유발된 흰쥐에 있어서 인슐린(insulin)의 분비를 다소 증가시켜주는 것으로 사료된다.As a result of comparing the weight of each group (see FIG. 9), the diabetic-induced groups gained weight over the breeding time than the control group, but were less than the normal group. This is because streptozotocin selectively destroys the beta cells of the pancreas (β-cell), leading to abnormalities in insulin (insulin) production, resulting in an imbalance of sugar metabolism, and thus, weight is not easily recovered. However, in the diabetic induction group, indigenous white rice and brown rice ganoderma lucidum rice groups gained more weight than the control group, and insulin secretion was observed in streptozotocin-induced diabetic rats by ingesting ganoderma lucidum rice. Is thought to increase slightly.
또한, 각 군의 식이 섭취량을 비교한 결과(도 10 참조), 당뇨 유발군들의 식이섭취량이 대조군의 식이 섭취량보다 낮게 나타났다. 이는 당뇨의 증상 중 다식증이라는 현상 때문이라고 판단되었다. 상기와 같은 결과에서 알 수 있듯이 본 발명의 토종 버섯 쌀은 우수한 항당뇨 활성을 나타내었다.
In addition, as a result of comparing the dietary intake of each group (see FIG. 10), the dietary intake of the diabetes-induced group was lower than the dietary intake of the control group. It was judged that this was due to a phenomenon called polyphagia among the symptoms of diabetes. As can be seen from the above results, the native mushroom rice of the present invention showed excellent antidiabetic activity.
실험예Experimental Example 3-3: 실험 쥐의 장기 무게 측정 3-3: Organ Weight Measurement in Experimental Rats
상기 실험에서 사육이 완료된 실험 쥐의 간장, 신장, 췌장 및 비장의 무게를 측정하기 위하여 실험동물로부터 각 장기를 적출해서 지방 및 결합조직을 제거한 후 생리식염수(0.9% NaCl)로 세척하고 여지로 수분을 제거한 후 무게를 측정하였다.In order to measure the weight of the liver, kidney, pancreas and spleen of the experimental rats in which the breeding was completed, each organ was removed from the experimental animals, and the fat and connective tissues were removed, and then washed with physiological saline (0.9% NaCl), and then water. After the removal was weighed.
NS: Not significantEach value is the mean ± SE (n = 8)
NS: Not significant
당뇨가 유발된 흰쥐에 토종 백미 및 현미 영지버섯 쌀을 14일간 급여한 후 흰쥐의 간, 신장, 비장 및 췌장의 무게를 측정한 결과(표 5 참조), 정상군, 대조군 및 당뇨유발 실험군들 간에 별다른 차이는 나타나지 않았다.
Diabetic rats were fed with white rice and brown rice ganoderma lucidum rice for 14 days, and then weighed rat liver, kidney, spleen and pancreas (see Table 5). There was no difference.
실험예Experimental Example 3-4: 토종 버섯 쌀 섭취에 따른 실험 쥐의 혈당 변화 비교 3-4: Comparison of Blood Glucose Levels in Experimental Rats According to Intake of Native Mushroom Rice
사육이 끝난 실험 쥐를 희생시키기 9시간 전부터 절식시키고 물만 공급하며, 에테르(ether)로 마취하여 복부대동맥으로부터 주사기로 채혈한 혈액은 4℃에서 원심분리(1,110×g/15분)하여 혈장으로 사용하였고, 혈장 포도당은 포도당 산화효소(glucose oxidase)법을 이용하여 측정하였다.9 hours before sacrifice, the rats were fasted and water was supplied. Anesthetized with ether, and blood collected by a syringe from the abdominal aorta was centrifuged at 4 ° C (1,110 × g / 15 minutes) and used as plasma. Plasma glucose was measured using glucose oxidase method.
토종 백미와 현미 영지버섯 쌀을 당뇨가 유발된 실험 쥐에게 14일간 투여시 나타나는 혈당의 변화를 비교한 결과(도 11 참조), 당뇨 유발 실험군들에서 모두 고혈당이 나타났지만, 토종 현미와 백미를 투여한 군들과 토종 현미와 백미 영지버섯 쌀을 투여한 군들이 대조군보다 유의적으로 혈당을 감소시켰음을 확인할 수 있었다. 특히, 토종 백미와 현미 영지버섯 쌀 투여군들은 대조군에 비해 혈당을 약 30% 감소시켜 인슐린(insulin)의 분비 증가와 췌장 베타 셀(β-cell)의 손상을 완하시키는 효과가 있는 것으로 판단되었다.
Comparing the changes in blood sugar levels of the white rice and brown rice ganoderma lucidum rice in the diabetic rats induced for 14 days (see FIG. 11), the hyperglycemia was observed in all of the diabetic rats, but the indigenous brown rice and white rice were administered. One group and the group treated with native brown rice and white rice ganoderma lucidum rice showed significantly lower blood sugar than the control group. In particular, the indigenous white rice and brown rice ganoderma lucidum rice groups were found to reduce blood sugar by about 30% compared to the control group to increase insulin secretion and alleviate damage to pancreatic beta cells (β-cell).
실험예Experimental Example 3-5: 토종 버섯 쌀 섭취에 따른 실험 쥐의 혈중 총 콜레스테롤 및 3-5: Serum Total Cholesterol and Plasma of Rats Treated with Indigenous Mushroom Rice 트리글리세라이드Triglyceride 함량 비교 Content comparison
당뇨병의 대사적 특징은 혈당의 상승과 비정상적인 지질대사이다. 혈당의 상승으로 지질과산화 반응을 유도하여 동맥경화증을 유발할 수 있으며, 혈당의 조절상태가 불량할수록 고지혈증이 심해지므로, 혈중 초저밀도 리포단백질(very low-density lipoprotein) 제거율이 감소 되어 혈중 총 콜레스테롤(total cholesterol)과 트리글리세라이드(triglyceride)가 증가 된다. 이에 실험 쥐의 혈중 총 콜레스테롤 및 트리글리세라이드 함량을 비교하여 토종 버섯 쌀 섭취의 항당뇨 활성을 확인하고자 하였다. Metabolic features of diabetes are elevated blood sugar and abnormal lipid metabolism. Increasing blood sugar can induce lipid peroxidation and induce atherosclerosis, and poorer control of blood sugar leads to severe hyperlipidemia, which reduces the removal rate of very low-density lipoproteins in the blood, thus reducing total cholesterol in the blood. cholesterol and triglycerides are increased. The purpose of this study was to determine the antidiabetic activity of native mushroom rice intake by comparing blood total cholesterol and triglyceride contents.
사육이 끝난 실험 쥐를 희생시키기 9시간 전부터 절식시키고 물만 공급하며, 에테르(ether)로 마취하여 복부대동맥으로부터 주사기로 채혈한 혈액은 4℃에서 원심분리(1,110×g/15분)하여 혈장으로 사용하였고, 총 콜레스테롤(total cholesterol)은 효소법, 트리글리세라이드(triglyceride)는 부코로(Bucolo)법을 이용하여 토종 버섯 쌀 섭취에 따른 실험 쥐의 혈중 총 콜레스테롤 및 트리글리세라이드의 함량을 측정하였다. 9 hours before sacrifice, the rats were fasted and water was supplied. Anesthetized with ether, and blood collected by a syringe from the abdominal aorta was centrifuged at 4 ° C (1,110 × g / 15 minutes) and used as plasma. Total cholesterol (tri-cholesterol) and triglyceride (triglyceride) were measured by the Buccoro (Bucolo) method to determine the total cholesterol and triglyceride content of blood in experimental rats according to the intake of native mushroom rice.
a, b, c Values with different superscript letters in the same column significantly different among the groups at p < 0.05.Each value is the mean ± SE (n = 8).
a, b, c Values with different superscript letters in the same column significantly different among the groups at p <0.05.
측정결과(표 6 참조), 당뇨 유발군들이 혈중 총 콜레스테롤(total cholesterol)과 트리글리세라이드(triglyceride)가 정상군보다 높게 나타났지만, 대조군 보다는 낮게 나타났다. 상기 결과로부터, 토종 백미와 현미 영지버섯 쌀의 섭취가 당뇨로 인한 혈장 총 콜레스테롤(total cholesterol)과 트리글리세라이드(triglyceride)의 증가를 유의적으로 억제했음을 확인할 수 있었다.
As a result of the measurement (see Table 6), the diabetic inducing group showed higher total cholesterol and triglyceride in the blood than the normal group, but lower than the control group. From the results, it was confirmed that ingestion of native white rice and brown rice ganoderma lucidum rice significantly inhibited the increase of total cholesterol and triglyceride due to diabetes.
실험예Experimental Example 3-6. 토종 버섯 쌀 섭취에 따른 3-6. Indigenous mushroom rice intake ASTAST 및 And ALTALT 활성도 측정 Activity measurement
ALT와 AST 활성은 간세포에 다량 존재하는 효소로 간 손상시 세포 외로 다량 유출되어 혈액에 증가됨으로써 간 손상의 지표로 이용되는 효소이다. 당뇨 시에 간장 내 지질 대사 이상을 초래하여 간장 손상을 일으켜 ALT와 AST가 증가하는 것으로 알려져 있다. 이에 본 실험에서는 토종 버섯 쌀 섭취에 따른 AST 및 ALT 활성도를 측정하고자 하였다. ALT and AST activity are enzymes that are present in large amounts in hepatocytes and are used as indicators of hepatic damage as they are leaked out of the cells and increased in the blood when the liver is damaged. In diabetes, hepatic lipid metabolism abnormality causes hepatic damage, which is known to increase ALT and AST. In this experiment, we tried to measure the activity of AST and ALT according to the consumption of native mushroom rice.
사육이 끝난 실험 쥐를 희생시키기 9시간 전부터 절식시키고 물만 공급하며, 에테르(ether)로 마취하여 복부대동맥으로부터 주사기로 채혈한 혈액은 4℃에서 원심분리(1,110×g/15분)하여 혈장으로 사용하였고, 에이에스티(AST) 및 에이엘티(ALT) 활성도는 라이트만 프란켈법(Reitman-Frankel)법에 의한 키트(kit, Sigma Co.)를 사용하여 측정하였다. 9 hours before sacrifice, the rats were fasted and water was supplied. Anesthetized with ether, and blood collected by a syringe from the abdominal aorta was centrifuged at 4 ° C (1,110 × g / 15 minutes) and used as plasma. The AST and ALT activities were measured using a kit (kit, Sigma Co.) by the Reitman-Frankel method.
a, b, c Values with different superscript letters in the same column significantly different among the groups at p < 0.05.Each value is the mean ± SE (n = 8).
a, b, c Values with different superscript letters in the same column significantly different among the groups at p <0.05.
측정결과(표 7 참조), 전체적으로 당뇨 유발군들이 ALT와 AST 활성이 높게 나타났는데, 이는 고혈당으로 인한 간장의 손상으로 추측된다. 또한, 토종 현미와 백미 영지버섯 쌀 군이 대조군보다 ALT와 AST 활성이 낮게 나타난 것은 토종 현미와 백미 영지버섯 쌀의 섭취가 고혈당으로 인한 간장 손상을 어느 정도 회복시켜 주는 것을 확인할 수 있다. As a result of the measurement (see Table 7), diabetic-induced groups showed high levels of ALT and AST activity, presumably due to high blood sugar damage to the liver. In addition, the indigenous brown rice and white rice ganoderma lucidum rice group showed lower ALT and AST activity than the control group, it can be seen that the intake of native brown rice and white rice ganoderma lucidum rice recovers to some extent hepatic damage caused by hyperglycemia.
Claims (2)
Method of producing a functional native white rice mushroom rice, characterized in that inoculated 7.5 ~ 12.5% (w / w) to Ganoderma lucidum mycelium in native white rice and incubated at 27 ~ 29 ℃ for 8 to 10 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120090566A KR20140024549A (en) | 2012-08-20 | 2012-08-20 | Method for manufacturing functional mushroom rice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120090566A KR20140024549A (en) | 2012-08-20 | 2012-08-20 | Method for manufacturing functional mushroom rice |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20140024549A true KR20140024549A (en) | 2014-03-03 |
Family
ID=50640114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120090566A KR20140024549A (en) | 2012-08-20 | 2012-08-20 | Method for manufacturing functional mushroom rice |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20140024549A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101662226B1 (en) | 2016-03-08 | 2016-10-04 | 최영주 | Fermented brown rice using Antioxidant composition and Method for producing thereof |
KR101671970B1 (en) | 2016-04-29 | 2016-11-03 | 최영주 | Brown rice using Fomes fomentarius and Calcium and Method for producing thereof |
-
2012
- 2012-08-20 KR KR1020120090566A patent/KR20140024549A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101662226B1 (en) | 2016-03-08 | 2016-10-04 | 최영주 | Fermented brown rice using Antioxidant composition and Method for producing thereof |
KR101671970B1 (en) | 2016-04-29 | 2016-11-03 | 최영주 | Brown rice using Fomes fomentarius and Calcium and Method for producing thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6383799B1 (en) | Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | |
US6316002B1 (en) | Germination activated red Ganoderma lucidum spores and method for producing the same | |
JP6548520B2 (en) | Insecticide having various effects and production method thereof | |
KR100199920B1 (en) | The method of culturing cordyceps | |
CN1358413A (en) | Method for preparing mushroom mycelium and use | |
CN102994305B (en) | Method for preparing health-care food (therapy) product (nutrient juice wine) by use of extracts from cordyceps militaris and cocoon | |
CN105641000A (en) | Antitumor composition containing grifola frondosus extract and preparation method thereof | |
KR20130077802A (en) | The preparing method of immune improving agents | |
CN109825533B (en) | Fermentation medium for preparing high-activity phellinus igniarius fermentation product and fermentation culture method thereof | |
CN101805763B (en) | Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity | |
CN107267403A (en) | Culture medium, hickory chick compound bacteria filament and the preparation method of Morchella esculenta (L.) Pers mycelium | |
TWI408226B (en) | Submerged cultivation of pleurotus eryngii mycelia high in ergothioneine content | |
KR101127271B1 (en) | Method of cultivating cordyceps sinensis and use of culture thereof | |
US20040106187A1 (en) | Composition for the culturing of Phellinus linteus mycelium | |
JP2012158536A (en) | Antidepressant | |
JP2002087981A (en) | Improving agent for metabolic disorder against sugar and lipid | |
KR20140024549A (en) | Method for manufacturing functional mushroom rice | |
CN105535035B (en) | A kind of Inonotus obliquus fermented and cultured composition and preparation method thereof | |
KR102580526B1 (en) | Method of Preparing Soybean Fermented Mycelium | |
KR20200094557A (en) | Composition to inhibit liver damage using mushroom mycelia germinated on naked barley medium and Manufacturing method thereof | |
KR20060116463A (en) | The hyphae of mushroom cultured in ginseng dregs, and the culturing method | |
KR20080079962A (en) | Hypoglycemic exopolysaccharides from tremella fuciformis mycellium and a preparation method thereof | |
CN114431460A (en) | Pure natural edible fungus nutrition powder and preparation method thereof | |
CN101172119A (en) | Cordyceps sinensis lucid ganoderma oral liquid and its preparing process | |
KR100706132B1 (en) | Composition for the culturing of Phellinus linteus mycelium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |